Two Sigma Advisers’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-148,500
Closed -$11.1M 968
2025
Q4
$11.1M Buy
+148,500
New +$10.9M 0.02% 508
2025
Q3
Sell
-7,200
Closed -$469K 2473
2025
Q2
$469K Sell
7,200
-26,600
-79% -$1.59M ﹤0.01% 1775
2025
Q1
$2.09M Buy
33,800
+2,800
+9% +$186K ﹤0.01% 1139
2024
Q4
$2.23M Buy
31,000
+13,600
+78% +$1.06M 0.01% 1069
2024
Q3
$1.42M Sell
17,400
-7,400
-30% -$592K ﹤0.01% 1249
2024
Q2
$1.84M Sell
24,800
-30,200
-55% -$2.26M ﹤0.01% 1235
2024
Q1
$4.29M Sell
55,000
-261,700
-83% -$19.5M 0.01% 839
2023
Q4
$22.6M Sell
316,700
-20,500
-6% -$1.43M 0.05% 304
2023
Q3
$23.4M Buy
337,200
+105,300
+45% +$7.96M 0.06% 275
2023
Q2
$18.8M Buy
231,900
+102,200
+79% +$8.35M 0.05% 318
2023
Q1
$10.5M Sell
129,700
-5,900
-4% -$475K 0.03% 541
2022
Q4
$10.1M Sell
135,600
-5,400
-4% -$385K 0.03% 507
2022
Q3
$9.1M Sell
141,000
-8,400
-6% -$582K 0.03% 521
2022
Q2
$10.4M Sell
149,400
-17,300
-10% -$1.28M 0.03% 494
2022
Q1
$12.8M Buy
166,700
+64,900
+64% +$4.67M 0.03% 432
2021
Q4
$7.79M Buy
+101,800
New +$7.48M 0.02% 588
2021
Q3
Sell
-1,135,000
Closed -$75.7M 2533
2021
Q2
$75.7M Buy
1,135,000
+412,100
+57% +$27.5M 0.2% 104
2021
Q1
$53.8M Sell
722,900
-99,400
-12% -$7.55M 0.15% 145
2020
Q4
$59.9M Sell
822,300
-136,020
-14% -$9.6M 0.16% 138
2020
Q3
$63.7M Sell
958,320
-920,300
-49% -$58.3M 0.18% 125
2020
Q2
$107M Sell
1,878,620
-64,100
-3% -$3.15M 0.31% 67
2020
Q1
$68.2M Sell
1,942,720
-69,600
-3% -$3.31M 0.26% 91
2019
Q4
$105M Buy
2,012,320
+921,500
+84% +$45.9M 0.24% 95
2019
Q3
$55.1M Buy
1,090,820
+682,300
+167% +$33.6M 0.13% 182
2019
Q2
$19.6M Sell
408,520
-220,600
-35% -$10.2M 0.05% 410
2019
Q1
$30.4M Sell
629,120
-600
-0.1% -$27.1K 0.08% 306
2018
Q4
$25.9M Sell
629,720
-307,943
-33% -$12.6M 0.07% 317
2018
Q3
$38.4M Sell
937,663
-335,900
-26% -$13.6M 0.09% 249
2018
Q2
$50.6M Sell
1,273,563
-1,167,400
-48% -$44.9M 0.14% 190
2018
Q1
$91.2M Sell
2,440,963
-387,348
-14% -$15.7M 0.25% 108
2017
Q4
$121M Buy
2,828,311
+620,761
+28% +$24.8M 0.33% 76
2017
Q3
$81M Buy
2,207,550
+181,787
+9% +$7.34M 0.23% 123
2017
Q2
$91.9M Sell
2,025,763
-272,100
-12% -$12M 0.3% 73
2017
Q1
$97.8M Buy
2,297,863
+398,244
+21% +$16.2M 0.32% 70
2016
Q4
$76.2M Buy
1,899,619
+178,428
+10% +$6.89M 0.29% 90
2016
Q3
$66.8M Sell
1,721,191
-45,854
-3% -$1.73M 0.28% 85
2016
Q2
$61.1M Buy
1,767,045
+429,000
+32% +$14.9M 0.31% 79
2016
Q1
$46.2M Sell
1,338,045
-69,885
-5% -$2.44M 0.26% 104
2015
Q4
$54.5M Sell
1,407,930
-8,443
-0.6% -$328K 0.32% 84
2015
Q3
$55.4M Buy
1,416,373
+811,775
+134% +$32.2M 0.35% 78
2015
Q2
$23M Buy
604,598
+23,753
+4% +$831K 0.17% 161
2015
Q1
$19.2M Sell
580,845
-74,740
-11% -$2.29M 0.14% 184
2014
Q4
$17.5M Sell
655,585
-121,360
-16% -$3.13M 0.14% 197
2014
Q3
$18.9M Sell
776,945
-128,700
-14% -$3.25M 0.14% 179
2014
Q2
$23M Buy
905,645
+494,400
+120% +$11.6M 0.18% 139
2014
Q1
$8.84M Buy
+411,245
New +$8.87M 0.08% 271
2013
Q4
Sell
-17,945
Closed -$371K 2418
2013
Q3
$371K Buy
+17,945
New +$382K ﹤0.01% 1563

Other funds holding HOLX

Two Sigma Advisers's HOLX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Hologic (HOLX) in Q1 2026, closing a stake of 148,500 shares — an estimated $11.1M sold.

Two Sigma Advisers first reported a position in HOLX in Q3 2013 and held it in 47 quarters. The position peaked at $121M in Q4 2017. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 148,500 Hologic shares in Q1 2026, an estimated $11.1M.
  • Two Sigma Advisers first reported a position in Hologic in Q3 2013 and held it in 47 quarters.
  • Two Sigma Advisers's Hologic position peaked at $121M in Q4 2017.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.